Type | Pathway | Gene name | P-value |
---|---|---|---|
Cancer pathways | Pathways in cancer | AR,EGLN1,JAG2,NOTCH4,WNT9B | 1.95 × 10−5 |
Breast cancer | WNT9B,NOTCH4,JAG2 | 0.001 | |
Notch signaling pathway | JAG2,NOTCH4 | 0.001 | |
Signaling pathways regulating pluripotency of stem cells | WNT9B,LIFR | 0.004 | |
Hippo signaling pathway | WNT9B,BMP6 | 0.004 | |
Wnt signaling pathway | NFATC4,WNT9B | 0.005 | |
Jak-STAT signaling pathway | LIFR,CRLF2 | 0.005 | |
MAPK signaling pathway | RPS6KA4,MAPK8IP3 | 0.015 | |
Basal cell carcinoma | WNT9B | 0.040 | |
Renal cell carcinoma | EGLN1 | 0.044 | |
Metabolic pathways | Metabolic pathways | PDE10A,PDE8A,ATP6V0A1,DEGS2,B3GNT4,FPGS | 0.001 |
Purine metabolism | PDE8A,PDE10A | 0.003 | |
Cushing syndrome | PDE8A,WNT9B | 0.004 | |
Folate biosynthesis | FPGS | 0.017 | |
Glycosphingolipid biosynthesis: lacto and neolacto series | B3GNT4 | 0.018 | |
Sphingolipid metabolism | DEGS2 | 0.030 | |
Ovarian steroidogenesis | BMP6 | 0.031 | |
Cortisol synthesis and secretion | PDE8A | 0.041 | |
Others | Cytokine-cytokine receptor interaction | BMP6,LIFR,CRLF2 | 0.001 |
Human papillomavirus infection | WNT9B,ATP6V0A1,NOTCH4 | 0.001 | |
RNA degradation | C1D,MPHOSPH6 | 0.001 | |
Morphine addiction | PDE8A,PDE10A | 0.002 | |
Endocrine resistance | JAG2,NOTCH4 | 0.002 | |
Collecting duct acid secretion | ATP6V0A1 | 0.018 | |
Circadian rhythm | B3GNT4 | 0.020 | |
Antifolate resistance | FPGS | 0.020 | |
Vibrio cholerae infection | ATP6V0A1 | 0.032 | |
Epithelial cell signaling in Helicobacter pylori infection | ATP6V0A1 | 0.044 | |
Antigen processing and presentation | KLRC2 | 0.049 | |
Synaptic vesicle cycle | ATP6V0A1 | 0.049 |